2nd Quarter - Report
AMERICAN CAPITOL GROUP for C-PATH INSTITUTE
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Reauthorization of the Critical Path Public Private Partnership Program. Food and Drug Safety and Innovations Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVE LARSON | — |
Budget/Appropriations BUD
FDA Appropriations for research projects related to FDA's Critical Path Public Private Partnership Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVE LARSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.